Chronic disease management platforms market seen growing 15% a year through 2030

The global market for chronic disease management platforms is projected to rise from $9.56 billion in 2026 to $16.72 billion by 2030, according to The Business Research Company. Growth is being driven by rising chronic illness rates, remote monitoring adoption and AI-enabled care tools, with North America leading and Asia-Pacific expected to grow fastest.

Why it matters: - Chronic disease management platforms are becoming a bigger part of care delivery as providers shift toward digital tools for monitoring, coordination and treatment support. - The market’s growth reflects rising demand for continuous patient tracking, better adherence support and earlier intervention for conditions such as diabetes, cardiovascular disease and asthma. - The expansion also signals more room for AI, remote monitoring and interoperable health data systems in routine care.

What happened: - The Business Research Company published its Chronic Disease Management Platforms Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on July 18, 2026. - The report says the market grew from $8.33 billion in 2025 to an expected $9.56 billion in 2026, a 14.8% compound annual growth rate. - The market is forecast to reach $16.72 billion by 2030, with a 15.0% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region through the forecast period.

The details: - Chronic disease management platforms are digital healthcare systems for continuous monitoring, coordination and management of long-term conditions. - The platforms use data integration, remote monitoring, analytics and communication tools to support clinical decision-making across the care continuum. - The report points to several growth drivers, including the global rise in chronic disease, wider telehealth adoption, stronger digital healthcare infrastructure, increased demand for continuous monitoring and more use of wearable medical devices. - The report identifies AI integration in clinical decision support, value-based care, remote patient monitoring, interoperability, personalized medicine and blockchain-based data exchange as key growth themes through 2030. - The report also highlights AI-driven predictive analytics, IoT-enabled monitoring networks, cloud-based electronic health records and precision medicine care pathways as major trends. - The analysis covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa in addition to North America and Asia-Pacific. - The 2026 report adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics and updated trend analysis. - A free sample of the report is available here. - The full report is available here.

Between the lines: - The forecast suggests chronic disease software is moving from a niche support tool to a core layer of care management as health systems try to handle more long-term patients. - The emphasis on AI, interoperability and remote monitoring shows that market growth is tied as much to infrastructure upgrades as to patient demand. - The report’s lifestyle-disease example reinforces that prevention and early detection are becoming central commercial arguments for these platforms. - In June 2024, the UK National Health Service said more than 549,000 additional people in England were identified in 2023 as at risk for type 2 diabetes. - The NHS also said that 3,615,330 people were registered with GPs for non-diabetic hyperglycemia in 2023, up from 3,065,825 in 2022. - That was an almost 20% increase year over year.

What's next: - The market is expected to keep expanding through 2030 as health systems add remote monitoring, predictive analytics and more connected care workflows. - Vendors are likely to compete more on interoperability, AI decision support and secure data exchange. - Adoption should remain strongest where chronic disease burdens are rising and digital health infrastructure is improving.

The bottom line: - Chronic disease management platforms are on track for rapid growth as providers look for scalable tools to manage long-term illness more proactively and at lower cost.